Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Waitlist-controlled Clinical Study on the Efficacy and Safety of Lingzhi-containing Dietary Supplement CP003 on Chronic Fatigue and Post-COVID Fatigue

NCT06739720 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06739720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06739720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Waitlist-controlled Clinical Study on the Efficacy and Safety of Lingzhi-containing Dietary Supplement CP003 on Chronic Fatigue and Post-COVID Fatigue
Lead sponsor
The University of Hong Kong
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 2, 2025
Completion date
December 31, 2026
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue syndrome (cfs), post-covid me/cfs